Key result
Nanoparticle technology offers a promising novel diagnostic strategy for targeting and imaging pathological biomarkers of vulnerable atherosclerotic plaques.
Why the study?
Current imaging technologies mainly focus on structural assessment and have disadvantages limiting imaging efficacy, requiring novel strategies like nanoparticles to delineate vulnerable atherosclerotic plaques.
Design
Review
Authors
Loading...
May advance molecular imaging of vulnerable plaques; leaves open clinical translation pending validation studies.
Nanoparticle technology offers a novel and promising approach to image pathological biomarkers of vulnerable atherosclerotic plaques, potentially overcoming the limitations of current structural imaging.
Zhang et al. (2022) conducted a review in Vulnerable atherosclerotic plaques. Nanoparticle technology for imaging was evaluated. Nanoparticle technology offers a promising novel diagnostic strategy for targeting and imaging pathological biomarkers of vulnerable atherosclerotic plaques.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: